STT
48
3
WHR
59
2
UAL
38
4
CMA
40
3
CPB
44
4
CCL
50
3
VLO
35
2
ED
33
3
PNR
62
3
SO
73
3
JWN
55
2
MOS
29
7
DVA
75
3
ACN
42
-16
DUK
64
5
RF
47
4
EXC
50
3
REGN
68
3
WY
40
13
CHRW
44
2
STT
48
3
WHR
59
2
UAL
38
4
CMA
40
3
CPB
44
4
CCL
50
3
VLO
35
2
ED
33
3
PNR
62
3
SO
73
3
JWN
55
2
MOS
29
7
DVA
75
3
ACN
42
-16
DUK
64
5
RF
47
4
EXC
50
3
REGN
68
3
WY
40
13
CHRW
44
2
Financhill
Back

Oracle Vs. Cytokinetics Industry Stock Comparison

Buy
65

ORCL
Oracle

Last Price:
139.13
Seasonality Move:
3.99%
Buy
52

CYTK
Cytokinetics

Last Price:
52.86
Seasonality Move:
5.69%
Buy
65
Oracle (ORCL) is a Buy

Is Oracle a Buy, Sell or Hold?

  • The current Oracle [ORCL] share price is $139.89. The Score for ORCL is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • ORCL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Cytokinetics (CYTK) is a Buy

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $53.85. The Score for CYTK is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ORCL Stock Price Chart

What is Oracle's stock price today?

  • The Oracle share price today is $139.89
    The current trend is moderately bullish and ORCL is experiencing slight selling pressure.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $53.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight buying pressure.

ORCL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.78 Buy
Relative Strength Index (14 RSI): 66.32 Buy
Chaikin Money Flow: -2772087 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (119.73 - 137.49) Buy
Bollinger Bands (100): (112.89 - 128.83) Buy

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.4 Sell
Relative Strength Index (14 RSI): 47.99 Sell
Chaikin Money Flow: 69998 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.06 - 56.58) Buy
Bollinger Bands (100): (56.38 - 74.98) Sell

ORCL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 141.08 Sell
20-day SMA: 129.69 Buy
50-day SMA: 122.94 Buy
200-day SMA: 115.18 Buy
8-day EMA: 138.85 Buy
20-day EMA: 132.56 Buy
50-day EMA: 126.13 Buy
200-day EMA: 116.42 Buy

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.08 Buy
20-day SMA: 51.6 Buy
50-day SMA: 58.73 Sell
200-day SMA: 55.73 Sell
8-day EMA: 53.02 Buy
20-day EMA: 53.6 Buy
50-day EMA: 57.71 Sell
200-day EMA: 56.9 Sell

Oracle Earnings Growth & ORCL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.03 per share, an increase this year of $0.55 per share, and an increase next year of $0.68 per share.

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.33 per share, an increase next quarter of $0.02 per share, an increase this year of $0.56 per share, and an increase next year of $0.15 per share.

Oracle Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):